Sethi Sanjeev, Palma Lilian Monteiro P, Theis Jason D, Fervenza Fernando C
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Pediatric Nephrology, State University of Campinas, Brazil.
Kidney Int Rep. 2023 Feb 3;8(4):827-836. doi: 10.1016/j.ekir.2023.01.030. eCollection 2023 Apr.
Complement plays an important role in the pathogenesis of glomerulonephritis (GN). Even though the underlying etiology of GN might be different, complement activation with subsequent glomerular deposition of complement proteins result in glomerular injury and progression of the lesions. Routine immunofluorescence microscopy (IF) includes staining for only complement factors C3c and C1q. Therefore, with regard to evaluation of the complement pathways, routine kidney biopsy provides only limited information.
In this study, using laser microdissection of glomeruli followed by mass spectrometry, complement proteins and pathways involved in GN were analyzed.
We found that C3 followed by C9 are the most abundant complement proteins in GN, indicating activation of classical or lectin or alternative, and terminal pathways, either exclusively or in a combination of pathways. Furthermore, depending on the type of GN, C4A and/or C4B were also present. Therefore, membranous nephropathy (MN), fibrillary GN, and infection-related GN showed C4A dominant pathways, whereas lupus nephritis (LN), proliferative GN with monoclonal Ig deposits, monoclonal Ig deposition disease (MIDD), and immunotactoid glomerulopathy showed C4B dominant pathways. Significant deposition of complement regulatory proteins, factor H-related protein-1 (FHR-1) and factor H-related protein-5 (FHR-5), were also detected in most GN.
This study shows accumulation of specific complement proteins in GN. The complement pathways, complement proteins, and the amount of complement protein deposition are variable in different types of GN. Selective targeting of complement pathways may be a novel option in the treatment of GN.
补体在肾小球肾炎(GN)的发病机制中起重要作用。尽管GN的潜在病因可能不同,但补体激活及随后补体蛋白在肾小球的沉积会导致肾小球损伤和病变进展。常规免疫荧光显微镜检查(IF)仅包括补体因子C3c和C1q的染色。因此,就补体途径的评估而言,常规肾活检仅提供有限的信息。
在本研究中,采用肾小球激光显微切割术,随后进行质谱分析,对GN中涉及的补体蛋白和途径进行分析。
我们发现,在GN中含量最丰富的补体蛋白依次为C3和C9,这表明经典途径、凝集素途径或替代途径以及终末途径被激活,要么是单独激活,要么是多种途径联合激活。此外,根据GN的类型,还存在C4A和/或C4B。因此,膜性肾病(MN)、纤维样肾小球肾炎和感染相关性肾小球肾炎显示C4A占主导的途径,而狼疮性肾炎(LN)、伴有单克隆Ig沉积的增生性肾小球肾炎、单克隆Ig沉积病(MIDD)和免疫触须样肾小球病显示C4B占主导的途径。在大多数GN中还检测到补体调节蛋白、H因子相关蛋白-1(FHR-1)和H因子相关蛋白-5(FHR-5)的显著沉积。
本研究显示了特定补体蛋白在GN中的蓄积。不同类型的GN中补体途径、补体蛋白及补体蛋白沉积量各不相同。选择性靶向补体途径可能是GN治疗的一种新选择。